Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi (Q34624438)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi |
scientific article |
Statements
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest (English)
Sergio Ricci
Isa Brunetti
Elisabetta Pfanner
Giacomo Allegrini
Cecilia Barbara
Lucio Crinò
Giovanni Benedetti
Walter Evangelista
Laura Fanchini
Enrico Cortesi
Vincenzo Picone
Stefano Vitello
Silvana Chiara
Cristina Granetto
Gianfranco Porcile
Luisa Fioretto
Cinzia Orlandini
Michele Andreuccetti
Gianluca Masi
Gruppo Oncologico Nord Ovest